EFTRW
eFFECTOR Therapeutics, Inc. Warrant
EFTRW
EFTRW
Delisted
EFTRW was delisted on the 2nd of July, 2024.
10 hedge funds and large institutions have $258K invested in eFFECTOR Therapeutics, Inc. Warrant in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
-1
Holders Change %
-9.09%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
1
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
-$6K
Top Buyers
1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
$1.42K |
Top Sellers
1 |
UBS Group
Zurich,
Switzerland
|
$0 |
2 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
$161K |